Introduction: Endometrial hyperplasia is a common disease and precursor of endometrial carcinoma. WHO hyperplasia classification system which is unreliable has confusing and overlapping criteria which prompted the development of a system based on Endometrial Intraepithelial Neoplasia (EIN). Objectives: (1) To review Endometrial Intraepithelial Neoplasia.(2) To reclassify WHO classification of endometrial hyperplasia into EIN and non-EIN category and to study the interobserver variability. Materials and Methods: In 102 patients diagnosed as WHO hyperplasia reclassification was done by 2 separate pathologists using EIN criteria 1) Glandular crowding. 2) Cytologic demarcation. 3) Size of the lesion should exceed 1mm. 4) Exclude benign processes 5) Exclude carcinoma. Inter observer variability was studied. Results: Out of 102 cases, 53 (51.96%) cases were earlier diagnosed as simple typical hyperplasia, 12 (11.76%) cases as complex typical hyperplasia, 21 (20.58%) cases as simple atypical hyperplasia and 16 (15.68%) cases as complex atypical hyperplasia. 26% were re-classified as EIN and 64% as non-EIN lesions by first pathologist. Second pathologist reclassified 28% as EIN and 62% as non-EIN lesions. Interobserver variability existed in only 2 cases of complex hyperplasia with atypia reclassified by second pathologist. Conclusion: EIN criteria has less interobserver variability than WHO classified hyperplasia system and can be easily applied to routine haematoxylin and eosin sections. EIN diagnosis prevents the progression to endometrial adenocarcinoma and helps in clinical management which is less intensive than for adenocarcinoma.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.